161 related articles for article (PubMed ID: 24405770)
1. Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases.
Wang S; Zhang C; Sheng X; Zhang X; Wang B; Zhang G
J Clin Neurosci; 2014 May; 21(5):810-4. PubMed ID: 24405770
[TBL] [Abstract][Full Text] [Related]
2. Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease.
Armentero MT; Sinforiani E; Ghezzi C; Bazzini E; Levandis G; Ambrosi G; Zangaglia R; Pacchetti C; Cereda C; Cova E; Basso E; Celi D; Martignoni E; Nappi G; Blandini F
Neurobiol Aging; 2011 Dec; 32(12):2142-51. PubMed ID: 20106550
[TBL] [Abstract][Full Text] [Related]
3. The role of mitogen-activated protein kinase pathways in Alzheimer's disease.
Zhu X; Lee HG; Raina AK; Perry G; Smith MA
Neurosignals; 2002; 11(5):270-81. PubMed ID: 12566928
[TBL] [Abstract][Full Text] [Related]
4. Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Ouyang M; Shen X
J Neurochem; 2006 Apr; 97(1):234-44. PubMed ID: 16515547
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.
Giovannini MG; Cerbai F; Bellucci A; Melani C; Grossi C; Bartolozzi C; Nosi D; Casamenti F
Neuroscience; 2008 May; 153(3):618-33. PubMed ID: 18406062
[TBL] [Abstract][Full Text] [Related]
6. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
7. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease.
Blandini F; Sinforiani E; Pacchetti C; Samuele A; Bazzini E; Zangaglia R; Nappi G; Martignoni E
Neurology; 2006 Feb; 66(4):529-34. PubMed ID: 16505307
[TBL] [Abstract][Full Text] [Related]
8. Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
Webber KM; Smith MA; Lee HG; Harris PL; Moreira P; Perry G; Zhu X
J Neurosci Res; 2005 Feb; 79(4):554-60. PubMed ID: 15635602
[TBL] [Abstract][Full Text] [Related]
9. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin gene expression in aortic regurgitation: relative roles of mitogen-activated protein kinases.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Ene AR; Herrold EM; Dumlao TF; Beltran F; Borer JS
Cardiology; 2009; 113(4):291-8. PubMed ID: 19299894
[TBL] [Abstract][Full Text] [Related]
12. Increases in phosphorylation of SAPK/JNK and p38MAPK correlate negatively with mouse embryo development after culture in different media.
Wang Y; Puscheck EE; Lewis JJ; Trostinskaia AB; Wang F; Rappolee DA
Fertil Steril; 2005 Apr; 83 Suppl 1():1144-54. PubMed ID: 15831287
[TBL] [Abstract][Full Text] [Related]
13. JNK activation by tetrahydrobiopterin: implication for Parkinson's disease.
Choi HJ; Lee SY; Cho Y; Hwang O
J Neurosci Res; 2004 Mar; 75(5):715-21. PubMed ID: 14991847
[TBL] [Abstract][Full Text] [Related]
14. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
Tan M; Wang S; Song J; Jia J
Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
[TBL] [Abstract][Full Text] [Related]
15. Compromised MAPK signaling in human diseases: an update.
Kim EK; Choi EJ
Arch Toxicol; 2015 Jun; 89(6):867-82. PubMed ID: 25690731
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase activates NF-κB via the ERK1/2 and p38MAPK Pathways in amyloid-β25-35-induced apoptosis in PC12 cells.
Wang X; Chen Q; Xing D
J Alzheimers Dis; 2012; 32(1):77-94. PubMed ID: 22776966
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
Chung J; Chavez PR; Russell RM; Wang XD
Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
[TBL] [Abstract][Full Text] [Related]
19. G1/S checkpoint proteins in peripheral blood lymphocytes are potentially diagnostic biomarkers for Alzheimer's disease.
Song J; Wang S; Tan M; Jia J
Neurosci Lett; 2012 Sep; 526(2):144-9. PubMed ID: 22922216
[TBL] [Abstract][Full Text] [Related]
20. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease.
Peng J; Andersen JK
IUBMB Life; 2003; 55(4-5):267-71. PubMed ID: 12880208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
